KRCA-0008
Product Sizes
10 mg
£ POA
HY-12331-10MG
25 mg
£ POA
HY-12331-25MG
5 mg
£ POA
HY-12331-5MG
100 mg
£ POA
HY-12331-100MG
50 mg
£ POA
HY-12331-50MG
10mM/1mL
£ POA
HY-12331-10MM
About this Product
- SKU:
- HY-12331
- CAS Number:
- 1472795-20-2
- Extra Details:
- KRCA-0008 is a selective ALK/Ack1 inhibitor with IC50s of 12 and 4 nM for ALK and Ack1; respectively. KRCA-0008 can be used for the research of cancer[1][2].
- Molecular Weight:
- 609.12
- Purity:
- 96.72
- References:
- [1]Park CH, et al. Novel bis-ortho-alkoxy-para-piperazinesubstituted-2,4-dianilinopyrimidines (KRCA-0008) as potent and selective ALK inhibitors for anticancer treatment. Bioorg Med Chem Lett. 2013 Nov 15;23(22):6192-6.|[2]Hwang J, et al. KRCA-0008 suppresses ALK-positive anaplastic large-cell lymphoma growth. Invest New Drugs. 2020 Oct;38(5):1282-1291.
- Research Area:
- Cancer
- Shipping Conditions:
- Ambient
- Storage Conditions:
- -20[o]C; 3 years; 4[o]C; 2 years (Powder)
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Small Molecules
- Pathway:
- Apoptosis;Protein Tyrosine Kinase/RTK
